Neurocrine Biosciences Reports First Quarter 2024 Financial Results
Go back to Neurocrine Biosciences Reports First Quarter 2024 Financial Results| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 156.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.76 | 52 Week High | $58.46 | |||
| Open | $156.76 | 52 Week Low | $31.25 | |||
| Day High | $156.76 | P/E | N/A | |||
| Day Low | $156.76 | EPS | $-0.69 | |||
| Volume | 139 | |||||

